September 3rd 2021
Best practices using available scoring systems to evaluate and treat patients with advanced hepatocellular carcinoma.
August 27th 2021
Perspectives regarding treatment advances using adjuvant approaches that include immunotherapy to treat early-stage hepatocellular carcinoma.
Reactions to recent clinical abstracts that support the use of hepatic arterial infusions for chemotherapy delivery in hepatocellular carcinoma.
August 20th 2021
Reactions to treatment gaps in the neoadjuvant space for hepatocellular carcinoma and implications for incorporating data supporting newer, novel systemic therapies for appropriate patients.
University of Arizona’s Rachna Shroff, MD, describes the role of systemic therapy with locoregional treatment for early stage hepatocellular carcinoma and highlights treatment strategies of interest that remain under investigation.
August 13th 2021
Edward Kim, MD, of Mount Sinai Health System describes where advances in locoregional therapy for early-stage hepatocellular carcinoma fit into the therapeutic landscape.
A debate regarding the current role of biopsy to confirm a diagnosis of early-stage hepatocellular carcinoma.
August 6th 2021
The rationale for diagnostic imaging to evaluate and diagnose early stage hepatocellular carcinoma.
A brief overview of criteria and tools used to assess, and risk stratify patients with early stage hepatocellular carcinoma.